Salton Completes Sale of Tabletop Assets for $14.2 Million; Divestiture Continues Company's Strategy to Focus on Core Brands
Posted on: Monday, 19 September 2005, 18:00 CDT
Salton, Inc. (NYSE: SFP) announced today that it has completed the sale of certain tabletop assets to Lifetime Brands, Inc. (NASDAQ: LCUT) for approximately $14.2 million. Under the transaction, Salton will divest the Block(R) and Sasaki(R) brands, licenses to market Calvin Klein(R) and NapaStyle(TM) tabletop products and distribution of upscale crystal products under the Atlantis(R) brand. In addition, Salton will enter into a new license with Lifetime Brands enabling it to market tabletop products under the Stiffel(R) brand.
"The divestiture of our tabletop assets represents another step in our plans to improve our balance sheet and focus on our core business," said Leon Dreimann, Salton's CEO. "This transaction, combined with the announced sale of our stake in Amalgamated Appliance and our recently completed Exchange Offer, improves the Company's liquidity and allows Salton to allocate resources to businesses in our core competencies."
About Salton, Inc.
Salton, Inc. is a leading designer, marketer and distributor of branded, high quality small appliances, electronics, home decor and personal care products. Its product mix includes a broad range of small kitchen and home appliances, electronics for the home, tabletop products, time products, lighting products, picture frames and personal care and wellness products. The company sells its products under a portfolio of well recognized brand names such as Salton(R), George Foreman(R), Westinghouse(TM), Toastmaster(R), Mellitta(R), Russell Hobbs(R), Farberware(R), Ingraham(R) and Stiffel(R). It believes its strong market position results from its well-known brand names, high quality and innovative products, strong relationships with its customers base and its focused outsourcing strategy.
Certain matters discussed in this press release are forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from those set forth in the forward-looking statements. These factors include: Salton's ability to close the sale of its 52.6% ownership interest in AMAP; Salton's ability to repay 10-3/4% Subordinated Notes due December 15, 2005 that remain outstanding after Salton's private exchange offer; Salton's ability to realize the benefits it expects from its U.S. restructuring plan; Salton's substantial indebtedness and restrictive covenants in Salton's debt instruments; Salton's ability to access the capital markets on attractive terms or at all; Salton's relationship and contractual arrangements with key customers, suppliers and licensors; pending legal proceedings; cancellation or reduction of orders; the timely development, introduction and customer acceptance of Salton's products; dependence on foreign suppliers and supply and manufacturing constraints; competitive products and pricing; economic conditions and the retail environment; the availability and success of future acquisitions; international business activities; the risks related to intellectual property rights; the risks relating to regulatory matters and other risks and uncertainties detailed from time to time in Salton's Securities and Exchange Commission Filings.
Source: Business Wire
Related Articles
- Stopain(R) Named a 'Demand Brand' by Mass Market Retailers Magazine
- Vertafore, Inc. Taps Seattle Integrated Advertising Agency, Worktank, to Drive Brand Development and Support Marketing and Sales
- Farmers Market-brand croutons are recalled
- New Conference Reveals How to Use Powerful Word-of-Mouth PR Tools to Drive Brand Loyalty, Media Coverage and Sales
- Synvista Therapeutics Increases Commercial Focus By Appointing David C. Tantillo Senior Director of Marketing and Sales
- Cyanotech Focuses Natural Astaxanthin Production on BioAstin(R) for Human Market, Discontinues Production of NatuRose(R) for Animal Feed Market in Strategic Move
- Reactrix Systems, Inc. Names New Vice President of Brand Solutions and Marketing
- CDEX Inc. Announces Expansion of Its ValiMed(TM) Marketing &Amp; Sales Team in the UK
- Novartis Suspends US Marketing and Sales of Zelnorm(R) in Response to Request From FDA
- Envirokare Announces LRM Industries Executive Appointment in Marketing and Sales
User Comments (0)

RSS Feeds